| 70748-299-01 |
70748-299 |
HUMAN PRESCRIPTION DRUG |
ATOVAQUONE |
ATOVAQUONE |
SUSPENSION |
ORAL |
20210601 |
N/A |
ANDA |
ANDA210692 |
Lupin Pharmaceuticals, Inc. |
ATOVAQUONE |
750 mg/5mL |
1 BOTTLE in 1 CARTON (70748-299-01) / 210 mL in 1 BOTTLE |
| 31722-629-21 |
31722-629 |
HUMAN PRESCRIPTION DRUG |
Atovaquone |
Atovaquone |
SUSPENSION |
ORAL |
20181011 |
N/A |
ANDA |
ANDA210692 |
Camber Pharmaceuticals, Inc. |
ATOVAQUONE |
750 mg/5mL |
1 BOTTLE in 1 CARTON (31722-629-21) / 210 mL in 1 BOTTLE |
| 17856-8631-1 |
17856-8631 |
HUMAN PRESCRIPTION DRUG |
Atovaquone |
Atovaquone |
SUSPENSION |
ORAL |
20251001 |
N/A |
ANDA |
ANDA210692 |
ATLANTIC BIOLOGICALS CORP. |
ATOVAQUONE |
750 mg/5mL |
50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-8631-1) / 5 mL in 1 CUP, UNIT-DOSE |
| 17856-0631-1 |
17856-0631 |
HUMAN PRESCRIPTION DRUG |
Atovaquone |
Atovaquone |
SUSPENSION |
ORAL |
20240904 |
N/A |
ANDA |
ANDA210692 |
ATLANTIC BIOLOGICALS CORP. |
ATOVAQUONE |
750 mg/5mL |
72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0631-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0631-2) |
| 72603-248-01 |
72603-248 |
HUMAN PRESCRIPTION DRUG |
Atovaquone |
Atovaquone |
SUSPENSION |
ORAL |
20240501 |
N/A |
ANDA |
ANDA210692 |
NorthStar RxLLC |
ATOVAQUONE |
750 mg/5mL |
1 BOTTLE in 1 CARTON (72603-248-01) / 210 mL in 1 BOTTLE |
| 60687-534-36 |
60687-534 |
HUMAN PRESCRIPTION DRUG |
Atovaquone |
Atovaquone |
SUSPENSION |
ORAL |
20230713 |
N/A |
ANDA |
ANDA210692 |
American Health Packaging |
ATOVAQUONE |
750 mg/5mL |
2 TRAY in 1 CASE (60687-534-36) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-534-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-534-40) |
| 60687-534-78 |
60687-534 |
HUMAN PRESCRIPTION DRUG |
Atovaquone |
Atovaquone |
SUSPENSION |
ORAL |
20201021 |
N/A |
ANDA |
ANDA210692 |
American Health Packaging |
ATOVAQUONE |
750 mg/5mL |
7 TRAY in 1 CASE (60687-534-78) / 6 CUP, UNIT-DOSE in 1 TRAY (60687-534-52) / 5 mL in 1 CUP, UNIT-DOSE (60687-534-40) |